deltatrials

Type 2 diabetes Trials in Caba, Argentina

Conditions / Type 2 diabetes / Caba, Argentina

Type 2 diabetes is a medical condition with active clinical research programs worldwide.

18 total trials for this combination

Showing top 10 of 18 trials

Trials

NCT ID Title Status Phase
NCT05872620 A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes COMPLETED PHASE3
NCT06131372 A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo COMPLETED PHASE2
NCT04657003 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight COMPLETED PHASE3
NCT06221969 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor COMPLETED
NCT06045221 A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin COMPLETED PHASE3
NCT06221969 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor COMPLETED
NCT05803421 A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk COMPLETED
NCT06037252 A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity ACTIVE_NOT_RECRUITING PHASE2
NCT06972472 A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes RECRUITING PHASE3
NCT06993792 A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes ACTIVE_NOT_RECRUITING

Related Pages